Ascribe Bioscience Inc. SBIR Phase II Award, March 2022
A SBIR Phase II contract was awarded to Acribe Biosciences in March, 2022 for $998,060.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
998,060
0
Government Branch
Date Awarded
March 10, 2022
0
End Date
February 28, 2025
0
SBIR/STTR Award Recipient
Contract Number (US Government)
2R44AI152915-02
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like Ascribe Bioscience Inc. SBIR Phase II Award, March 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.